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To develop the SBC for family planning business case, we 
drew on nearly 200 studies assessing SBC effectiveness 
and/or costs across a range of countries. We looked at 
both the indirect impact of SBC interventions via inter-
mediate outcomes such as attitudes toward and 
communication around family planning, and the direct 
impact of SBC interventions on modern contraceptive 
use. Across studies, we calculated impact factors using 
odds ratios (ORs) to standardize the relationship between 
exposure to the SBC intervention and outcomes.1 From 
these ORs, we constructed an impact matrix for three 
SBC intervention types: interpersonal communication 
(IPC); mass, digital, and social media; and packages that 
combine SBC approaches. Although community mobiliza-
tion and community participation were extracted from 
the impact literature as unique interventions, due to the 
limited number of results, the difficulty in assessing these 
interventions (which often included some form of media 
and/or IPC) as primarily community mobilization or 
participation, and the fact that most packages included 
community activities, we decided to combine the results 
from community mobilization and participation with 
packages. For each intervention type, we populated the 
impact matrix with a median OR, and a lower and upper 
range around that median value to capture the variation 
1An OR less than 1 implies a negative relationship between the interven-
tion and the outcome; whereas a ratio greater than 1 implies a positive 
relationship.
in impact across studies. For SBC costs, we translated 
findings from all studies into United States dollars (USD) 
2017 (Box 1). We then calculated a median and lower and 
upper range cost per person exposed for these SBC 
intervention categories: television, radio, group IPC, 
individual IPC, and packages. We conducted modeling 
using these matrices and additional input data to calcu-
late the costs and associated impacts of scaling up SBC 
interventions. Note that while cost data were extracted 
for other specific forms of media in addition to television 
and radio (e.g., newspapers, billboards, live drama, digital 
media), there were far fewer data points for these forms 
of media, and the broad ranges of the costs indicated 
serious differences in costing methodology. Thus, only 
television and radio were included in the modeling. 
To answer questions about the cost-effectiveness of SBC 
and whether it generates a good return on investment, 
we present two case examples of SBC programming 
BOX 1  SBC COST STUDY REPOSITORY
Breakthrough RESEARCH has established a 
repository of SBC cost studies for use by research-
ers, program implementers, and funders. Now 
available on request as an Excel file, the project 
is building out an online version of the repository 
expected to be available by September 2020.
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from the literature. We also used the data to model the 
scaling of SBC programming in two settings, Guinea and 
Zambia. We estimate the cost of SBC by using existing 
cost repository data; we also account for the direct 
service delivery cost data associated with additional 
use of modern contraception.2 We estimated the health 
impact of SBC by translating additional use of modern 
contraception into maternal health gains that result from 
fewer unwanted pregnancies and reduced maternal 
deaths. These maternal health gains were then translated 
into disability-adjusted life-years (DALYs) averted using 
the Impact 2 model.3 To gauge the cost-effectiveness of 
SBC, we compared cost per DALY averted from SBC to 
international standards for cost-effectiveness of health 
interventions, which characterize an intervention as 
“highly cost-effective” if its cost per DALY averted is less 
than one times the gross domestic product (GDP) per 
capita of the country. We also calculated a return on 
investment by dividing the monetary benefit from SBC 
for family planning by its cost. To estimate monetary ben-
efits, we used the Impact 2 model to calculate the direct 
health service costs saved when averting an unintended 
pregnancy. We also estimated savings from productivity 
losses averted based on international guidelines suggest-
ing that between one and three times GDP per capita is 
saved for every DALY averted. 
Key findings of our work
• SBC is effective in improving health outcomes, 
but results vary by setting. Drawing on 130 unique 
studies that measured both the direct impact of SBC 
on modern contraceptive use and its indirect impact 
through intermediate outcomes, the analysis found 
many SBC interventions have a positive impact on 
intermediate outcomes as well as directly on mod-
ern contraceptive use. The median OR (drawn from 
ORs, or adjusted odds ratios [AORs] where available) 
ranged between 0.9 and 2.1 for all intervention types 
and all intermediate outcomes. These intermediate 
outcomes in turn were found to have a positive 
2Regional averages from Guttmacher’s Adding it Up 2017 Methodology 
Tables applied to country specific method mix based on DHS to estimate 
a unit cost per family planning user. This cost includes commodities, 
supplies, and salaries associated with clinical service provision.
3A disability-adjusted life-year (DALY) is a year lost to poor health, 
disability, or early death. The number of DALYs that any particular health 
intervention averts is one way of comparing effectiveness across a range 
of health interventions.
impact on modern contraceptive use, with median 
ORs ranging between 1.1 and 2.8. The analysis also 
found SBC interventions have a positive impact on 
modern contraceptive use directly, with median ORs 
between 1.3 and 1.6. 
• SBC costs range widely across and within inter-
vention types. Drawing on 53 unique studies from 
a range of countries and a variety of interventions, 
the analysis found that mass media interventions had 
significantly lower costs per person reached ($0.12 
for TV and $0.26 for radio) compared to interper-
sonal communication ($5.04 for individual and $6.92 
for group) and packages that combine multiple SBC 
approaches (between $11 and $21). Moreover, 
within each intervention type, costs can vary signifi-
cantly by setting. It is important to assess these cost 
differences in the broader context of the relative 
effectiveness and appropriateness of any particular 
intervention given the audience that an intervention 
wants to reach and the desired behavioral outcome.
• SBC is a highly cost-effective intervention. Using 
case examples from the research literature, and 
drawing from modeling in Zambia and Guinea, we 
found that scaling SBC is a highly cost-effective 
health intervention. Cost per DALY averted of SBC 
for family planning was $468 in Egypt, $591 in the 
Philippines, $1,051 in Zambia, and $438 in Guinea. 
All of the results fall below the one times GDP per 
capita threshold for classification as a highly cost-ef-
fective intervention. When compared against nearly 
100 health interventions in developing countries, 
SBC falls within the middle range of cost per DALY 
averted. 
• SBC generates a positive return on investment. The 
business case modeling found that, for example, in 
Zambia, for every $1 invested in scaling up SBC inter-
ventions, SBC saves between $2.40 and $5.30 when 
accounting for direct health care costs and produc-
tivity losses. In Guinea, $1 invested in SBC generates 
between $2.30 and $6.10 in savings.
Call to action
The Breakthrough RESEARCH business case finds that SBC 
interventions for family planning are effective, and in the 
examples explored, are highly cost-effective and gener-
ate a positive return on investment. Given these findings, 
we suggest the following calls to action:
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• Invest more in SBC for family planning. Given the 
health and economic benefits of SBC, policy mak-
ers should consider investing more in this proven 
approach. At the same time, policy makers should 
understand that the SBC impact in a country will vary 
depending on what interventions are scaled, exist-
ing levels of modern contraceptive use, prevailing 
attitudes, and the potential number of women and 
men SBC interventions are able to reach. 
• Use the results of this business case to advocate 
for increased SBC funding. Program implementers 
and advocates within the SBC community can use 
the results of the business case to help policy makers 
understand the value of SBC efforts by showcasing 
that SBC improves family planning outcomes, leads 
to better health outcomes, is cost-effective, and can 
lead to substantial cost savings. 
• Generate additional evidence of cost and effective-
ness. Evidence of cost and effectiveness forms the 
heart of the business case analysis. Evidence gaps 
exist, particularly for relatively new SBC approaches. 
Researchers, program implementers, and funders 
should invest in updating and improving the cost and 
impact databases, adding case examples, collecting 
standardized costing data, and generating new 
evidence of cost-effectiveness from rigorous and 
high-quality studies (Box 2).
• Conduct more country modeling. The examples 
for Guinea and Zambia show the potential power of 
the business case for advocacy at the country level. 
The SBC community can apply a similar modeling 
approach in other countries, in combination with 
other advocacy efforts, to provide evidence to 
increase SBC investments or to defend the current 
level of investment in SBC efforts in different contex-
tual settings.
• Prioritize SBC investments based on potential 
impact and cost-effectiveness. Among the various 
SBC interventions, we found differences in effec-
tiveness and cost. In deciding how to structure an 
SBC strategy for a country or developing tailored 
sub-national SBC plans, program managers and pol-
icy makers need better information on the relative 
cost-effectiveness of the SBC approaches to combine 
with other feasibility and contextual factors in their 
decision making. Further analysis of the existing 
data on effectiveness and costs, and the generation 
of evidence to fill current knowledge gaps can help 
achieve that goal (Box 3).
 
Box 3. Briefs on prioritizing SBC investments for 
BOX 3  BRIEFS ON PRIORITIZING SBC  
               INVESTMENTS FOR YOUTH
Breakthrough RESEARCH has developed two 
briefs exploring the factors related to adoles-
cent childbearing and youth contraceptive use 
in USAID priority countries to show how social 
behavior change (SBC) investments can be 
tailored to focus on the unique circumstances 
of different young people. “Prioritizing and 
targeting SBC investments to address adoles-
cent pregnancy in USAID priority countries” 
and “Prioritizing and targeting SBC investments 
in family planning for married youth in USAID 
priority countries” are available at https://
breakthroughactionandresearch.org/prioritiz-
ing-and-targeting-sbc-investments-for-youth/
BOX 2  SBC COSTING GUIDELINES
Breakthrough RESEARCH’s “Guidelines for 
Costing of Social and Behavior Change Health 
Interventions” offer standardized and detailed 
information on the approaches for high-qual-
ity and applicable costing of SBC programs. 
The Guidelines are available at https://break-
throughactionandresearch.org/our-work/
costing-and-economic-evaluation/
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Introduction
Why is an SBC business case 
needed?
The development field considers social and behav-
ior change (SBC) interventions an essential part of 
high-quality health services, and practitioners agree 
that improving health outcomes requires changing 
the health-seeking behaviors of individuals and com-
munities, as well as the norms that underpin those 
behaviors (United States Agency for International 
Development’s [USAID] 2016; Social and Behavior Change 
Communication [SBCC] Summit Secretariat 2018). Yet, 
gaps in information on the costs and impacts of SBC 
interventions have resulted in an incomplete picture 
of the contribution of SBC to health outcomes and the 
associated costs. One result is that decision makers 
have under-appreciated and under-funded SBC relative 
to its actual worth. This business case for SBC uses an 
evidence-based approach to address this imbalance by 
answering questions about the effectiveness, cost-effec-
tiveness, and return on investment of SBC. 
USAID asked Breakthrough RESEARCH in late 2017 to 
begin building a business case for SBC. In March 2018, 
Breakthrough RESEARCH held an expert consultation 
that helped to develop a common understanding of 
and consensus on the purpose, structure, and audience 
for a Breakthrough RESEARCH SBC business case. From 
these foundations and subsequent discussions with 
USAID, Breakthrough ACTION, and other stakeholders, 
Breakthrough RESEARCH prepared, and USAID approved 
in July 2018, a detailed concept note describing the 
approach. In September 2018, Breakthrough RESEARCH 
developed a Roadmap that expanded on that concept 
note. This document summarizes results from a subse-
quent literature review and modeling exercise.
What is a business case?
With origins in the commercial world, the business case 
in the global health field has come to mean a written or 
oral argument for investing in a particular health area or 
intervention, more specifically, one that analyzes the 
costs and returns of such an investment.4 A business case 
typically values returns in monetary terms, such as health 
system costs saved and productivity losses averted from 
improved health outcomes, and in terms of comparable 
health outcomes such as lives saved, disability-adjusted 
life years (DALYs) averted, or quality-adjusted life years 
(QALYs) gained. A commercial business case helps gauge 
the value of a specific investment: Do we build a new 
factory or not? Do we upgrade the company’s computer 
infrastructure or not? The emphasis in global health has 
been on using a business case to advocate for greater 
investment in a particular health area or intervention.5
What is the purpose of the SBC 
business case?
The primary purpose of this Breakthrough RESEARCH SBC 
business case is to provide rigorous evidence to show 
that investing in SBC is crucial for improving program 
outcomes and assuring health and development impact. 
In turn, we expect these arguments to influence the 
funding and programming decisions of international and 
in-country funders and health officials. The essence of 
the SBC business case approach is to capture SBC impact 
and cost measures, assess the benefit of SBC in health 
terms (cost-effectiveness analysis) or monetary terms 
(benefit-cost analysis), and transmit this evidence to key 
audiences to inform their advocacy efforts. 
By highlighting the economic dimension of SBC invest-
ments, this SBC business case closely aligns with and 
complements Breakthrough ACTION’s SBC for family 
planning “Influence Strategy” (Box 4) and the work of 
the Partnership for Maternal, Newborn, and Child Health 
(PMNCH) on an investment case for social, behavioral 
and community engagement (SBCE) interventions for 
reproductive, maternal, newborn and child health (Box 5).
4The global health field uses the terms “business case” and “investment 
case” interchangeably.
5See, for example, Thurston and Forbes 2014, “The business case for 
female condoms."
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costs and returns of such an investment.4 A business case 
typically values returns in monetary terms, such as health 
system costs saved and productivity losses averted from 
improved health outcomes, and in terms of comparable 
health outcomes such as lives saved, disability-adjusted 
life years (DALYs) averted, or quality-adjusted life years 
(QALYs) gained. A commercial business case helps gauge 
the value of a specific investment: Do we build a new 
factory or not? Do we upgrade the company’s computer 
infrastructure or not? The emphasis in global health has 
been on using a business case to advocate for greater 
investment in a particular health area or intervention.5
What is the purpose of the SBC 
business case?
The primary purpose of this Breakthrough RESEARCH SBC 
business case is to provide rigorous evidence to show 
that investing in SBC is crucial for improving program 
outcomes and assuring health and development impact. 
In turn, we expect these arguments to influence the 
funding and programming decisions of international and 
in-country funders and health officials. The essence of 
the SBC business case approach is to capture SBC impact 
and cost measures, assess the benefit of SBC in health 
terms (cost-effectiveness analysis) or monetary terms 
(benefit-cost analysis), and transmit this evidence to key 
audiences to inform their advocacy efforts. 
By highlighting the economic dimension of SBC invest-
ments, this SBC business case closely aligns with and 
complements Breakthrough ACTION’s SBC for family 
planning “Influence Strategy” (Box 4) and the work of 
the Partnership for Maternal, Newborn, and Child Health 
(PMNCH) on an investment case for social, behavioral 
and community engagement (SBCE) interventions for 
reproductive, maternal, newborn and child health (Box 5).
4The global health field uses the terms “business case” and “investment 
case” interchangeably.
5See, for example, Thurston and Forbes 2014, “The business case for 
female condoms."
Who is the SBC business case for?
The SBC business case aims to reach a range of primary 
audiences, including:
• International donors already funding SBC activities, 
to persuade them to maintain or increase their 
funding.
• International donors not currently funding SBC 
activities, to persuade them of the value of initiating 
SBC funding.
• Health ministries, including program officials, to 
persuade them that investments in SBC activities can 
enhance the impact of their efforts.
• Finance ministries, to persuade them that investing 
in SBC activities produces net societal benefits.
• Other government ministries, who may be coordinat-
ing SBC efforts with the health sector.
Additional audiences for this SBC business case include 
SBC implementing partners, researchers evaluating 
programs, and global bodies such as WHO, UNFPA, and 
UNICEF in their coordinating capacities. These individuals 
and groups can advocate for SBC using this business case. 
BOX 4  ALIGNMENT WITH THE SBC INFLUENCE STRATEGY OF BREAKTHROUGH ACTION
Breakthrough ACTION—USAID’s flagship SBC implementation project—is leading development of a new 
global influence strategy to increase commitment to SBC for family planning programming and initiate 
discussion on identifying shared priorities to catalyze coordination among stakeholders and create impact in 
family planning through SBC. The influence strategy aims to address limited understanding of, investment in, 
and coordination on SBC. Supporting the development of the influence strategy is an analysis of spending on 
SBC for family planning and interviews with experts and stakeholders to gauge understanding of SBC and to 
highlight key obstacles to SBC investment. From this analysis, Breakthrough ACTION is developing a strategy 
and set of activities that work through three pathways: (1) leveraging multi-stakeholder country planning 
processes; (2) directly engaging targeted donors; and (3) elevating SBC programming at existing fora.
BOX 5  ALIGNMENT WITH THE PMNCH SBCE INVESTMENT CASE
The Partnership for Maternal, Newborn, and Child Health (PMNCH), a global alliance of more than 1,000 
organizations from 192 nations, is developing an investment case for social, behavioral, and community 
engagement (SBCE) interventions for reproductive, maternal, newborn, and child health. Work to date has 
included an evidence gap map on SBCE interventions, a scoping exercise to gather insights from key stake-
holders, and a planned analysis on the benefits and costs of SBCE interventions (Pantoja 2017).
©2012 Leigh Wynne/FHI 360, Courtesy of Photoshare
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What is SBC?
An effective business case clearly defines the investment 
and its goals. Doing so helps to provide a common under-
standing of the parameters of the business case and 
to determine its scope. USAID’s High Impact Practices 
Initiative defines SBC as activities or interventions that 
seek to understand and facilitate change in behaviors and 
the social norms and environmental determinants that 
drive those behaviors.6 SBC interventions are grounded in 
behavioral theory and are informed by research and pro-
grammatic experience. Drawing on a variety of disciplines 
including marketing, advocacy, behavioral economics, 
human-centered design, and social psychology, SBC pro-
grams often consider social norms and dynamics in their 
design and implementation. SBC includes both commu-
nication and non-communication approaches to address 
behavior change, including communication between 
health workers and their clients, and engagement with 
community leaders and other influencers.7 
To turn this definition into a set of identifiable SBC inter-
ventions, we adapted the PMNCH SBCE investment case 
framework (Portela et al. 2017) to delineate broad inter-
vention categories; some adaptation from the framework 
was made to align with the available evidence on both 
impact and cost (Table 1). For example, although commu-
nity mobilization and participation was designated by the 
PMNCH SBCE framework and extracted from the impact 
literature as a unique intervention category, due to the 
limited number of results, the difficulty in assessing 
these interventions (which often included some form of 
media and/or IPC) as primarily community mobilization or 
participation, and the fact that most packages included 
community activities, we decided to combine the results 
from community mobilization and participation with 
packages. These categories can apply to any public health 
area or sector. 
6Family planning high impact practices, https://www.fphighimpactprac-
tices.org/briefs/sbc-overview/ .
7For more, see USAID. 2018. Social and behavior change. https://
www.usaid.gov/what-we-do/global-health/cross-cutting-areas/
social-and-behavior-change .  
Provider behavior change (PBC; also known as provider 
training and service delivery adjustments in the PMNCH 
SBCE investment case framework) is an SBC intervention 
type that is of increasing priority for donors and partners 
(Breakthrough RESEARCH 2018) and therefore, this work 
sought to identify the cost and impact of PBC. However, 
numerous challenges were encountered. First, there 
was difficulty in both defining and identifying in the 
literature what would be classified as training for pro-
vider behavior change (e.g., reduction in provider bias, 
improved methods for provider communication such as 
motivational interviewing) versus training for standard of 
care; similarly, it was challenging to delineate between 
service delivery adjustments that may be considered 
SBC vs. those that would be considered a health systems 
or supply-side intervention. Second, a limited number 
of studies were identified; results of these few studies 
showed a wide range of both impacts and costs. Third, 
limited data exist to understand the current situation 
with regards to provider-client interactions. Therefore, 
PBC has not been included as an intervention within this 
business case. However, as new evidence is generated 
around PBC this is an intervention area that could be 
added in a future iteration of the business case. 
TABLE 1  SBC INTERVENTION CATEGORIES AND 









Other (includes mid-media, live drama, 
digital, and social media)
 IPC
Individual/household IPC and counseling
Group IPC, incl. all peer and popular leader 
interventions
Packages 
IPC and community participation 
IPC and mass media  
Other combinations (including community 
mobilization)
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What is the effectiveness of SBC 
for family planning?
A good business case demands a clear vision of the 
health impact of the investment. For the SBC business 
case, impact occurs when research shows that an SBC 
intervention, activity, or program results in a quantifiable 
change in a behavioral outcome. For family planning, the 
priority behavior is the voluntary use of modern contra-
ceptive methods by women and men of reproductive 
age. Using studies from the existing literature on SBC 
effectiveness, we examined different pathways to impact 
on modern contraceptive use.8 We looked at both the 
indirect impact of SBC interventions via intermediate 
outcomes such as attitudes toward family planning and 
communication around family planning; and the direct 
impact of SBC interventions on modern contraceptive 
use (Figure 1). The standard measure we used to quantify 
the relationship between exposure to the SBC interven-
tion and outcome was the OR (Box 6). Our main findings 
follow.
8See Appendix 1 for detail on methods for impact analysis.
There is a lot of evidence on the effectiveness of SBC 
for family planning interventions, although some gaps 
persist. Our analysis drew on 130 studies from a range 
of countries and spanning many different types of SBC 
interventions for family planning.9 Still, clear gaps in 
the evidence exist, especially around provider behavior 
change interventions and for some newer SBC interven-
tions including digital media. This in part reflects the 
natural time lag between when new SBC interventions 
appear on the scene and when the field has generated a 
9Some studies contributed multiple results to a single pathway (for 
example, included results related to multiple intermediate outcomes). In 
addition, 27 studies contributed results to multiple pathways. Therefore, 
study numbers listed below sum to more than 130.
3
BOX 6  UNDERSTANDING ODDS RATIOS
An OR less than 1 implies a negative relationship 
between the intervention and the outcome; a 
ratio greater than 1 implies a positive relation-
ship between the intervention and the outcome. 
For example, a radio show that aims to improve 
attitudes toward family planning with an OR of 
2 implies that those exposed to the show have 
twice the odds of having a positive attitude com-
pared to those not exposed. The magnitude of 
the impact of any intervention is dependent not 
only on the OR, but also both the base¬line levels 
(e.g., what share of the population already have 
a positive attitude) and the change in coverage 
(e.g., how many people are reached).  Further, 
although the higher the OR the greater the 
relationship between intervention and outcome, 
the incremental impact of the OR differs (e.g., the 
increase in positive attitudes from an OR increas-
ing from 1.2 to 1.3 is not the same as the change 
from an OR increasing from 2.2 to 2.3).  Therefore 
looking at the size of the OR alone is not enough 
to tell us about potential impact.
FIGURE 1  INDIRECT AND DIRECT PATHWAYS 
                  FROM SBC TO MODERN  
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sufficient body of evidence to gauge the impact of new 
approaches. 
SBC has a positive impact on most intermediate 
outcomes, although the impact varies depending on 
the intervention type and intermediate outcome.10 We 
found a modest impact of SBC interventions on interme-
diate outcomes based on results from 49 studies (Figure 
2). With the exception of IPC interventions’ impact on 
communication with others about family planning, the 
median OR was greater than one for all intervention 
10It is likely that impact also varies by other factors such as population 
targeted and duration of intervention. We extracted this information, but 
did not include in the final analysis because a) a number of intervention/
outcome/target population/duration combinations would have had very 
little or no data for some pathways and b) this may overly complicate the 
analysis for the purposes of the business case; note that many more lines 
would be going from the circles to the boxes in Figure 2.
types and all intermediate outcomes. Thus, on average, 
exposure to an SBC intervention will result in an increase 
in one of the intermediate outcomes. 
Intermediate outcomes have a positive impact on mod-
ern contraceptive use, although some intermediate 
outcomes seem to matter more than others do. Based 
on our analysis of 46 studies that linked intermediate out-
comes to modern contraceptive use, we found a positive 
relationship for all intermediate outcomes, although 
the strength of that relationship varies. Communication 
between partners around family planning had the 
strongest link to modern contraceptive use, followed by 
beliefs regarding approval of family planning (Figure 3). 
This set of evidence includes non-intervention studies, 
since the intention is to understand the role of the inter-
mediate outcomes in influencing modern contraceptive 
FIGURE 2  MEDIAN ODDS RATIOS, RELATIONSHIP BETWEEN SBC INTERVENTION AND 
                  INTERMEDIATE OUTCOME, BY INTERVENTION TYPE AND INTERMEDIATE OUTCOME
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FIGURE 3  MEDIAN ODDS RATIOS, RELATIONSHIP BETWEEN INTERMEDIATE OUTCOME 
                  AND MODERN CONTRACEPTIVE USE
Note: width of line shows magnitude of OR on a log scale
Attitude:
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use—whether or not an SBC intervention influenced the 
intermediate outcomes. 
Via the direct link, SBC interventions have a positive 
impact on modern contraceptive use. Drawing on 69 
studies that measured the direct link between SBC inter-
ventions and modern contraceptive use, we also found 
a positive impact for all four intervention types. The 
relationship was strongest for IPC, followed by packages, 
and mass media (Figure 4).
In summary, SBC is effective at increasing modern 
contraceptive use, but there is a lot of variation in results. 
Some interventions are more effective than others, 
and this effectiveness varies depending on the type of 
intermediate outcome at which we are looking. Further, 
the impact that SBC will have in a country is not only 
determined by these ORs, but also by baseline levels of 
modern contraceptive prevalence rate (mCPR), baseline 
attitudes and communication, and how many women and 
men SBC interventions are able to reach. It is important 
to consider that variation when making decisions about 
whether and how much to invest in SBC, particularly in 
relationship to other family planning interventions. 
FIGURE 4  MEDIAN ODDS RATIOS, DIRECT RELATIONSHIP BETWEEN SBC INTERVENTION 
                  AND MODERN CONTRACEPTIVE USE
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What does SBC for family 
planning cost?
Understanding the costs of the investment is key to any 
good business case. Cost is the monetary value of all the 
resources required to carry out an SBC intervention, such 
as labor, commodities, materials, supplies, equipment, 
vehicles and other transport costs, training, supervi-
sion, management, space, and utilities. Unit costs are 
expressions of total costs on a per-person, per-event, or 
per-service basis. Cost-effectiveness ratios evaluate inter-
ventions in terms of health outcomes and benefit-cost 
ratios evaluate interventions in monetary terms.11 
What we know about SBC for family planning costs comes 
from a literature review and analysis carried out in 2018 
11For more on costs, see Rosen, J, DeCormier Plosky W, Bollinger L. 2019. 
Guidelines for Costing of Social and Behavior Change Health Interventions. 
Washington, DC: Breakthrough RESEARCH. https://breakthroughactionan-
dresearch.org/our-work/costing-and-economic-evaluation/
and 2019. The results we present here, drawn from 
studies that go back to the 1980s, are shown in 2017 US 
dollars. We present unit costs as cost per person exposed 
to the intervention (for mass media) or per person partic-
ipating in the intervention (for other interventions) (see 
Appendix 2 for more details on the literature review and 
analysis). Our main findings follow. 
There is some information on SBC costs, but gaps 
persist. We drew on 53 studies that produced 130 cost 
estimates. These come from a range of countries and 
study designs. The included costs and the level of detail 
authors provide on costs can vary widely from study to 
study. Moreover, interventions can vary in their intensity 
and comprehensiveness, and many study reports pro-
vide only limited intervention detail, thus complicating 
interpretation of these factors, particularly for package 
interventions.
4
©2012 RJCabagnot, Courtesy of Photoshare
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Costs range widely across and within intervention 
types. TV and radio mass media cost $0.12 and $0.26 
per person exposed. Group IPC cost $6.92 per person 
participating, and individual IPC cost $5.94 per person 
participating. Cost per person participating in packages is 
even higher, between $11 and $21 per person, depend-
ing on the combination (Figure 5). Within intervention 
types, there is quite a wide range of results around the 
median cost presented here. For example, radio costs 
between $0.14 and $0.75 per person exposed; group IPC 
ranges from $3.28 to $15.58 per person participating 
(see Appendix 2). The costs also may vary due to differ-
ent economic structures of the various countries. It is 
important to assess these cost differences in the broader 
context of the relative effectiveness and appropriateness 
of any particular intervention given the audience that 
an intervention wants to reach and the desired behav-
ioral outcome. While evidence was not sufficient to 
sub-divide the impact of different types of mass media, 
IPC, and packages, on the cost side, more detailed cost 
breakdowns could be generated. For the purpose of this 
business case we focus on just two-sub categories for 
each SBC intervention; however, more detailed results 
are available (see Appendix 2). 
Evidence is lacking for current, expanded SBC 
approaches. There is very little cost evidence on social 
media and digital SBC approaches. Similarly, newer 
approaches such as streaming versus live radio lack good 
costing evidence. The evidence on costs of integrated 
SBC is also limited.
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Is SBC for family planning  
cost-effective? Does it generate a 
good return on investment?
We took a two-fold approach to answering questions 
about the cost-effectiveness of SBC and whether it gen-
erates a good return on investment. First, we use case 
examples from the literature drawn from family planning 
studies that have both cost and impact, and have done a 
full analysis (or done it in a way that allows us to com-
plete a cost-effectiveness analysis). Second, because few 
such studies exist, we do modeling for two countries that 
gives insights into SBC cost-effectiveness by leveraging 
what we know about SBC impact and SBC costs. 
How do we know if SBC is  
cost-effective? 
Cost-effectiveness analysis places a value on a health 
investment in terms of the cost to achieve a health 
outcome. In the health field, a standard way to gauge 
the cost-effectiveness of an intervention is to use the 
incremental cost-effectiveness ratio (ICER). The ICER is 
determined by dividing the additional cost of an interven-
tion by its additional effectiveness. For the SBC for family 
planning business case, the main measure of effec-
tiveness is the DALY averted, one of the effectiveness 
measures traditionally used to compare a wide range of 
health interventions. To calculate DALYs averted in the 
analysis shown in this section, we convert additional 
family planning users using country- and method-spe-
cific coefficients from FP2020 Core Indicators and Marie 
Stopes International’s (MSI) Impact 2 model.12 The Impact 
2 model measures DALYs averted from both maternal and 
child health gains associated with family planning use. For 
purposes of this business case analysis, however, we take 
a more conservative approach and use only the DALYs 
averted produced by maternal health gains, in line with 
current guidance discouraging inclusion of child health 
12For more on MSI’s Impact 2 model, see: https://mariestopes.org/
media/3321/methodology_paper_june_2018-1.pdf and  http://impact-
calculator .psi .org/ .
impacts in calculating DALYs averted from family planning 
use (Askew et al. 2017). This is important to note when 
comparing the ICERs generated by this analysis with 
other, previous calculations of family planning effective-
ness and cost-effectiveness. 
Once you have calculated an ICER for an intervention, 
how do you know if it is cost-effective? There are two 
main ways, both of which we use to gauge the results 
of this SBC business case. The first, which we use in this 
business case, is to benchmark against international 
standards for cost-effectiveness of health interventions. 
Following the recommendations of the Commission 
on Macroeconomics and Health, The World Health 
Organization’s WHO-CHOICE initiative set standards for 
cost-effectiveness in terms of cost per DALY averted, clas-
sifying interventions as:
• Highly cost-effective (if the ICER is less than one times 
gross domestic product [GDP] per capita) 
• Cost-effective (if the ICER is between one and three 
times GDP per capita) or
• Not cost-effective (if the ICER is higher than three 
times GDP per capita)
A second way to gauge the cost-effectiveness of SBC is to 
compare its ICER against the ICERs of other, similar health 
interventions. This ranking should, however, be done 
with caution. First, because SBC is more akin to a health 
system intervention than to the clinical interventions 
which are the subject of most cost-effectiveness anal-
ysis. Second, because methods can vary greatly across 
studies. A recent synthesis of a large number of cost-ef-
fectiveness studies presents health interventions in three 
categories: less than $100 per DALY averted, between 
$100 and $1,000 per DALY averted, and greater than 
$1,000 per DALY averted (Horton et al. 2017).13 Overall, 
the study found that over half of the 93 interventions 
13Costs are in USD 2012.
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considered cost less than $200 per DALY averted, in USD 
2012. 
How do we know if SBC provides a 
good return on investment? 
Another form of economic evaluation, return on 
investment or benefit-cost analysis, values a particular 
investment in purely monetary terms. The simplest way 
to calculate a benefit-cost ratio is to divide the expected 
monetary benefit from the intervention by its cost. If an 
intervention costs $1 and generates $3 in benefits, the 
benefit-cost ratio is 3. Any investment with a benefit-cost 
ratio greater than 1 is considered a good investment. For 
this SBC for family planning business case, we calcu-
late two types of monetary benefits associated with 
increased family planning use: health service costs saved 
when averting an unintended pregnancy, and produc-
tivity loss saved when averting the maternal illness and 
death associated with unintended pregnancy. We derived 
estimates of health service cost savings from the Impact 
2 model. We estimated productivity loss averted based 
on international guidelines suggesting that between one 
and three times GDP per capita is saved for every DALY 
averted.14 
Case examples from the literature
We present two case examples of SBC studies from 
the literature with both cost and impact results (see 
Appendix 3 for more on how we chose these studies).15
Case example 1:  
SBC programming in Egypt
The Egyptian government has a long history of mass 
media activities aimed at behavior change, including 
increasing demand for family planning by improving 
knowledge and attitudes toward family planning to influ-
ence reproductive intentions and behaviors. Robinson 
and Lewis (2003) examined the costs and impacts of four 
separate mass media campaigns over two years. 
14See, for example, Jamison et al. 2013a and Jamison et al. 2013b, 
Supplementary Appendix 3, Table A 3.10.
15For comparability to the country modeling results below, we translated 
findings into USD 2017. We extended study results by estimating DALYs 
averted and service delivery costs from additional family planning users 
using the methods described in Appendix 4.
The campaigns aimed to reach approximately 10 million 
married women aged 15–49 and their spouses with 
access to television. Each of the four campaigns had a 
distinct focus:
• The Doctor Karima Mukhtar campaign consisted of 
a television drama series featuring a female doctor 
answering questions and addressing attitudes about 
the benefits and safety of family planning.
• The Gold Star Clinic campaign included television 
spots as well as print advertising and outreach 
activities to inform the public about designated 
“Gold Star” family planning providers with verified 
high-quality practices in order to increase demand 
for family planning services provided at these clinics, 
which were primarily intrauterine devices (IUDs).
• The Private Sector Initiative Ask-Consult campaign 
aimed to facilitate better communication and inter-
action between clients and private sector providers, 
especially pharmacists who dispensed oral birth 
control pills. The television spots were designed to 
increase demand for quality services and employed a 
new logo and “Ask-Consult” slogan.
• The Ahmed Maher Male Responsibility campaign was 
a series aimed at influencing the attitudes of men 
for taking responsibility for family planning along 
with their partners. As such, the campaign focused 
primarily on male methods, predominantly condoms.
In evaluating the effectiveness of these campaigns, 
researchers first examined the campaigns’ reach, as mea-
sured by exposure, through population surveys. Overall, 
the campaigns were largely successful in reaching their 
desired population, with an estimated exposure of 45 
percent for the Ahmed Maher campaign, 70 percent 
for Karima Muktar, 81 percent for Gold Star Clinic, and 
83 percent for Ask-Consult. Researchers also linked 
the campaigns to the rise in the modern contraceptive 
prevalence rate over the two-year period (48 percent to 
55 percent). Based on these calculations, they estimated 
that the campaigns generated 1.2 million additional 
users. 
The cost per person exposed ranged from $0.03 in the 
Karima Mukhtar to $0.15 for the Ahmed Maher cam-
paign. Adjusting for inflation, the four media campaigns 
cost $3.07 per additional user in 2017 dollars, and $8.50 
when accounting for the direct service delivery costs 
associated with these additional users. This translates to 
an ICER of $468 per DALY averted, well under the one 
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times GDP per capita threshold for highly cost-effective 
interventions and in the middle range of developing 
country health interventions. 
Case example 2:  
Family planning television campaign in 
the Philippines
In the Philippines, the Department of Health ran a 
nationwide family planning television campaign to 
promote modern contraceptive use. Formative research 
found that a husband’s support for family planning was 
important and that women wanted a contraceptive 
method that was hiyang, meaning “a natural fit to one’s 
body.” As such, the campaign aimed to increase contra-
ceptive prevalence by improving the attitudes toward 
modern contraceptives, both generally and specifically 
among husbands, and generating spousal communication 
around family planning. Based on these objectives, the 
campaign produced four advertisements featuring an 
attractive couple with two children discussing how family 
planning has enhanced their lives. The ads ended with 
the Secretary of Health promising that local providers can 
help women find a contraceptive method that is hiyang 
for them. 
Six months after the broadcasts ended, a national survey 
evaluated the campaign. The survey captured exposure 
to the campaign based on recall of campaign images and 
slogans as well as attitudes toward family planning and 
family planning use. Using the survey data, Kincaid and 
Do (2006) employed a combination of three different 
analytical techniques for a methodologically rigorous 
approach called multivariate causal attribution to test 
for a causal relationship between the SBC intervention 
and family planning use. Overall, they found that the 
campaign resulted in a 6 percent increase in modern con-
traceptive use, yielding nearly 350,000 additional modern 
contraceptive users. The total cost of the campaign was 
approximately $550,000, including costs for design, 
pretesting, production, and broadcasting. The total costs 
translated to $0.10 per woman exposed.
Adjusting for inflation, the campaign would cost $1.94 
per additional user in 2017 dollars, and $7.00 when 
accounting for the direct service delivery costs associ-
ated with these additional users. This would result in an 
ICER of $591 per DALY averted in 2017 dollars, which is 
highly cost-effective as a health intervention using the 
one times GDP per capita threshold, and in the middle 
range of developing country health interventions.
Country-level modeling of SBC 
cost-effectiveness and return on 
investment benefit
A limited number of studies assess the cost-effectiveness 
of SBC for family planning interventions. However, as we 
showed in sections 3 and 4, much larger evidence bases 
exist with information on the impact of SBC for family 
planning interventions and the costs of SBC for family 
planning interventions separately. We can thus model the 
potential cost-effectiveness of SBC for family planning 
interventions for a specific country by leveraging this 
information along with country program and demo-
graphic data (see Appendix 4 for detail on the modeling 
approach).
For this business case modeling, we selected two 
countries, Zambia and Guinea, which provide contrasting 
examples of the potential role of SBC for family planning 
in countries with very different levels of modern contra-
ceptive use and demand. They are also two countries 
where Breakthrough ACTION is applying its SBC for family 
planning influence strategy (section 1). Results from the 
two countries cannot be directly compared because each 
has a different context and SBC scale up plan. Rather, the 
results reflect the unique situations and scale up in each 
country and not relative differences in the cost-effective-
ness of SBC in the two countries. Further, these results 
reflect a single scale up scenario and are based on the 
impacts and costs found within the summary matrices. 
They are also desk studies, and thus their findings would 
benefit from having further validation of assumption 
in-country. Thus, the reader should take these as illustra-
tive results. 




In 2018, 36 percent of all women, and 49 percent of 
married/in-union women were using a modern method 
of contraception.16 According to the most recent Demo-
graphic and Health Survey (DHS) (2014), the mean ideal 
number of children was 4.7, and the total fertility rate 
was 5.3. The maternal mortality ratio in 2015 was 224, 
which is much lower than the average for sub-Saharan 
Africa, which was 547 in 2015 (WHO et al. 2015).
16Track20/family planning2020 Progress Report 
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Zambia performs well on most of the intermediate out-
comes considered, with the exception of communication 
with others where only 28 percent of women reported 
talking about family planning with their friends or neigh-
bors (2001/2 DHS) (Table 2).17 
How.does.the.modeling.scale.up.SBC.interventions.in.
Zambia?
Scale up was aligned as best as possible to SBC-related 
interventions described in Zambia’s Family Planning 
17Questions on approval and communication about family planning are 
no longer asked in DHS surveys, so we are reliant on older data for these 
indicator baselines.
Services Integrated Family Planning Scale Up Plan (2013–
2020). The plan sets out an ambitious goal of reaching 58 
percent mCPR among married women by 2020 through 
six strategic priorities related to demand generation, 
adolescents, training, reaching underserved populations, 
addressing stock outs, and improving coordination. 
Demand generation activities include the development 
and roll out of multi-media campaigns, and training 
national and community level national champions. Details 
from the plan-related scale up of specific interventions 
or introduction of new activities were converted into 
increases in coverage of SBC interventions (Table 3). 
TABLE 2  BASELINE VALUES FOR INTERMEDIATE OUTCOMES, ZAMBIA
INTERMEDIATE  
OUTCOME
% SOURCE AND INDICATOR 
Beliefs on approval of family 
planning
82 Zambia DHS 2001/2; respondent approves of family planning (“Would you say that you ap-
prove or disapprove of couples using a contraceptive method to avoid getting pregnant?")
Attitudes on the benefits, safety, 
and effectiveness of family 
planning
75 Zambia 2003–05 study; inverse of % of respondent reporting concerns or worries about 
contraception (average for injectable and pill—most common method):  
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825682/
Attitudes around intentions and 
self-efficacy of family planning
76 Zambia DHS 2014: Can ask partner to use condom
Attitudes regarding men’s role in 
family planning
65 Zambia DHS 2014: Decision making for family planning— jointly with partner
Communication between part-
ners about family planning
70 Zambia DHS 2001/2; discussed with spouse at least once
Communication with others 
about family planning
28 Zambia DHS 2001/2; discussed with friend/neighbor (highest of the non-partner  
responses)
TABLE 3  SCALE UP MODELED IN ZAMBIA






Radio 30 Coverage split between radio and TV; radio listener group overall removed. Plan 
suggests wide-scale use of radio and TV messages; coverage established based 
on DHS data on share of women who regularly listen to/watch radio and TV.† TV 20
IPC
Group 6 Coverage from community health champions split between group and individual 
Individual 5
Packages
IPC & community  
mobilization
8 Coverage based on community health campaigns
IPC & mass media 1 Coverage based on radio listener groups
† Due to a lack of information on the expected reach/exposure of the mass media campaign, the percent who listen to or watch radio and TV regularly 
was used as a proxy for exposure, representing an upper bound of potential reach.
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What.does.modeling.say.about.the.impact.of.SBC.in.
Zambia?.
Scaling up SBC interventions according to the coverage 
levels shown in Table 3 contributes to a 5 percentage 
point increase in mCPR over five years (2019 to 2023). 
This increase in mCPR translates into 535,900 additional 
users in 2023 (as compared to 2018). Cumulatively over 
the five years, this additional modern contraceptive use 
averts 578,800 unintended pregnancies and 46,400 
DALYs. 
The SBC intervention contributing the most to the 
increase in mCPR is mass media, which accounts for over 
half (57 percent) of the increase; this is partly due to the 
much higher coverage levels of mass media than other 
SBC interventions (Table 3). The remainder of the impact 
is split fairly evenly between packages and IPC (Figure 6).
In terms of intermediate outcomes, increases in partner 
communication play the largest role leading to changes 
in modern contraceptive use, accounting for just over 
40 percent of the increase (Figure 7). Three other 
intermediate outcomes also have sizable contributions: 
communication with others (26 percent), beliefs on 
approval of family planning (14 percent), and attitudes 
toward family planning (8 percent).
What.does.modeling.say.about.the.cost.and.cost-effec-
tiveness.of.SBC.in.Zambia?
The total cost of implementing the planned SBC inter-
ventions ranges from $28.2m to $58.8m; with a median 
cost estimate of $38.3m cumulatively over the five-year 
period (assuming steady scale up during the period).18 
Another $10.5m is needed for direct service delivery 
costs related to the additional users. 
The SBC ICERs are $30 per additional user19, $84 per 
pregnancy averted, and $1,051 per DALY averted (Figure 
8).20  
18The SBC cost reflects sensitivity analysis around key cost parameters 
(see Appendix 4).
19This calculation includes the interim years between 2018 and 2023, so is 
in essence the cost per “adopter year” over this period. 
20The graphs show the results based on median unit cost, and the range 
around this median cost using the 25th percentile (Q1) and 75th percen-
tile (Q3) findings from the unit cost matrix described in section 4).
FIGURE 6  RELATIVE CONTRIBUTION OF EACH 
                  SBC INTERVENTION TO INCREASE IN 
                  mCPR, ZAMBIA
FIGURE 7  INCREASE IN mCPR BY SBC 
                  INTERVENTION AND  






















Mass media IPC Packages
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 Even accounting for wide variation in SBC costs, this 
SBC scale up scenario produces a cost per DALY averted 
considered “highly cost effective” by WHO standards, 
falling below one times GDP per capita of $1,535 (blue 
line in Figure 8).21 and just slightly above the middle range 
of Horton et al.’s (2017) rankings.
21Additional sensitivity analysis finds that under almost all scenarios, SBC 
remains a highly cost-effective intervention in Zambia.
Benefit-cost analysis finds that, for every $1 invested in 
scaling up SBC interventions in Zambia, nearly $1 is saved 
in direct health care costs, and between $2.40 and $5.30 
is saved when including productivity losses (Figure 9).
In sum, scaling up SBC in Zambia is effective in increasing 
modern contraceptive prevalence, is a highly cost-ef-
fective intervention, and generates a positive return on 
investment.
FIGURE 8  THREE MEASURES OF COST-EFFECTIVENESS OF SBC, ZAMBIA 
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In 2018, 11 percent of all women, and 7 percent of mar-
ried/in-union women were using a modern method of 
contraception.22 The maternal mortality ratio in 2015 was 
679, which is higher than the average for sub-Saharan 
Africa, which was 547 in 2015 (WHO et al. 2015).
Guinea has low to moderate starting levels on most of 
the intermediate outcomes considered for the modeling. 
Approval of family planning has the highest rating, but 
even then, just under half of women report approving of 
family planning (2005 DHS) (Table 4).23 
22Track20/family planning2020 Progress Report 
23Questions on approval and communication about family planning are 




Scale up was aligned as best as possible to SBC-related 
interventions described in the National Budgeted Action 
Plan for Family Planning (2019–2023). This plan sets out 
a goal of reaching an mCPR among all women of 18.52 
percent by 2030 by addressing five areas: demand cre-
ation, supply and access to services, commodity security, 
enabling environment, and coordination. Within demand 
creation there are three objectives: improving the quality 
of family planning messages, increasing the commitment 
of men in gender promotion and support for modern 
contraceptive use, and addressing the reproductive 
health needs of adolescents (not included in the mod-
eling). Details from the plan-related scale up of specific 
interventions or introduction of new activities were 




Scaling up SBC interventions in Guinea according to 
the coverage levels shown in Table 5 contributes to a 3 
percentage point increase in mCPR over five years (2019 
to 2023). This increase in mCPR translates into 166,500 
TABLE 4  BASELINE VALUES FOR INTERMEDIATE 
                OUTCOMES, GUINEA 
INTERMEDIATE  
OUTCOME
% SOURCE AND INDICATOR 
Beliefs on approval of 
family planning
49 Guinea 2005 DHS: respon-
dent approves of family 
planning (“Would you 
say that you approve or 
disapprove of couples using 
a contraceptive method to 
avoid getting pregnant?")
Attitudes on the 
benefits, safety, and 
effectiveness of family 
planning
n/a No baseline data for this 
outcome could be located
Attitudes around inten-
tions and self-efficacy 
of family planning
24 Guinea 2012 DHS: Can ask 
partner to use condom
Attitudes regarding 
men’s role in family 
planning
30 Guinea 2012 DHS: Decision 
making for family plan-
ning— jointly with partner
Communication be-
tween partners about 
family planning
10 Guinea 2005 DHS: dis-
cussed with spouse at least 
once
Communication with 
others about family 
planning
21 Guinea 2005 DHS: dis-
cussed with friend/
neighbor (highest of the 
non-partner responses)






Mass media: radio 41 Plan only indicates radio 
programming not TV, 
so coverage allocated 
to radio. Plan suggests 
wide-scale use of radio 
messages; coverage es-
tablished based on DHS 
data on share of women 
who regularly listen to 
radio.
Mass media: TV 0
IPC: group 5 Includes women’s 
groups, husbands' 
schools, religious and 
community leaders. 
Mostly group, but small 
share allocated to indi-
vidual
IPC: individual 2
Packages: IPC &  
community mobi-
lization
3 National campaigns and 
community dialogue.
Packages: IPC & 
mass media
0 Not indicated in plan
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additional modern contraceptive users in 2023 (as 
compared to 2018). Cumulatively over the five years, this 
additional use averts 135,700 unintended pregnancies 
and 34,800 DALYs. 
The SBC intervention contributing the most to the 
increase in mCPR is mass media, which accounts for more 
than three quarters (78 percent) of the increase; this is 
partly due to the much higher coverage levels of mass 
media than other SBC interventions (Table 5). IPC inter-
ventions account for 14 percent of the increase in mCPR, 
while packages account for the remaining 8 percent 
(Figure 10). 
In terms of intermediate outcomes increases, the change 
in mCPR is fairly evenly attributed to increases in beliefs 
on approval of family planning, increases in communica-
tion with others, and increases in partner communication 
(each accounting for 22 percent to 34 percent of the 
total). Around 15 percent of the increase is not directly 
attributable to one of the intermediate outcomes, related 




The total cost of implementing the planned SBC interven-
tions ranges from $8.2 to $21 million, with a median cost 
estimate of $12.2 million cumulatively over the five-year 
period (assuming steady scale up during the period).24 
Another $3 million is needed for direct service delivery 
costs related to the additional users. 
The SBC ICERs are $30 per additional user25, $112 per 
pregnancy averted, and $438 per DALY averted (Figure 
12).26
24The SBC cost reflects sensitivity analysis around key cost parameters 
(see Appendix 4).
25This calculation includes the interim years between 2018 and 2023, so is 
in essence the cost per “adopter year” over this period. 
26The graphs show the results based on median unit cost, and the range 
around this median cost using the 25th percentile (Q1) and 75th percen-
tile (Q3) findings from the unit cost matrix described in section 4).
FIGURE 10  CONTRIBUTION OF EACH SBC  
                    INTERVENTION TO INCREASE IN 
                    mCPR, GUINEA
FIGURE 11  INCREASE IN mCPR BY SBC  
                    INTERVENTION AND  
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Even accounting for wide variation in SBC costs, this SBC 
scale up scenario produces cost per DALY averted results 
considered “highly cost effective” by WHO standards, 
falling below 1 times GDP per capita of $822 (blue line in 
Figure 12).27 and in the middle range of what Horton et 
al. (2017) finds. Benefit-cost analysis finds that, for every 
27Additional sensitivity analysis finds that under almost all scenarios, SBC 
remains a highly cost-effective intervention in Guinea.
$1 invested in scaling up SBC interventions in Guinea, 
SBC saves nearly $0.50 in direct health care costs, and 
between $2.30 and $6.10 in total when accounting for 
productivity loss averted (Figure 13).
In sum, scaling up SBC in Guinea is effective in increasing 
modern contraceptive prevalence, is a highly cost-ef-
fective intervention, and generates a positive return on 
investment.
FIGURE 12  THREE MEASURES OF COST-EFFECTIVENESS OF SBC, GUINEA 
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Call to action
This business case set out to answer, using an 
evidence-based approach, questions about the effec-
tiveness, cost-effectiveness, and return on investment 
of family planning SBC interventions. The literature 
review and analysis, case examples from the research 
literature, and the results of country modeling in Guinea 
and Zambia confirm that SBC interventions for family 
planning are effective, and, in the examples explored, are 
highly cost-effective and generate a positive return on 
investment. Given these findings, we suggest the follow-
ing calls to action:
• Invest more in SBC for family planning. Given the 
health and economic benefits of SBC, policy mak-
ers should consider investing more in this proven 
approach. At the same time, policy makers should 
understand that the SBC impact in a country will vary 
depending on what interventions are scaled, existing 
levels of modern contraceptive use, prevailing atti-
tudes, and the potential number of women and men 
SBC interventions are able to reach. It is important to 
consider that variation when making decisions about 
whether and how much to invest in SBC, particularly 
in relationship to other family planning interventions.
• Use the results of this business case to advocate 
for increased SBC funding. Program implementers 
and advocates within the SBC community can use 
the results of the business case to help policy makers 
understand the value of SBC efforts by showcasing 
that SBC improves family planning outcomes, leads 
to better health outcomes, is cost-effective and can 
lead to substantial cost savings.
• Generate additional evidence of cost and effective-
ness. Evidence of cost and effectiveness forms the 
heart of the business case analysis. Evidence gaps 
exist, particularly for relatively new SBC approaches. 
Researchers, program implementers, and funders 
should invest in updating and improving the cost and 
impact databases, adding case examples, collecting 
standardized costing data, and generating new 
evidence of cost-effectiveness from rigorous and 
high-quality studies.28 
• Conduct more country modeling. The examples 
for Guinea and Zambia show the potential power of 
the business case for advocacy at the country level. 
Those in the SBC community can apply a similar 
modeling approach in other countries, in combina-
tion with other advocacy efforts, to provide evidence 
to increase SBC investments or to defend the current 
level of investment in SBC efforts.
• Provide guidance on the relative cost-effectiveness 
of various SBC approaches. Among the various 
SBC interventions, we found differences in effec-
tiveness and cost. In deciding how to structure an 
SBC strategy for a country or developing tailored 
sub-national SBC plans, program managers and pol-
icy makers need better information on the relative 
cost-effectiveness of the SBC approaches to combine 
with other feasibility and contextual factors in their 
decision making. Further analysis of the existing 
data on effectiveness and costs and the generation 
of evidence to fill current knowledge gaps can help 
achieve that goal. 
To achieve these next steps requires cooperation, inspira-
tion, ideas, and funding from the broader SBC funding, 
implementing, advocacy, and research communities. 
Funders are key to increasing SBC spending, and can help 
pay for the analytics needed to refine the business case. 
Implementers can partner with research organizations 
to design and carry out studies. Researchers can guide 
the SBC community in its search for relevant studies 
and provide feedback on analytical methods. Advocates 
and all other stakeholders can provide insight on effec-
tive advocacy messages. Together, the SBC community 
can build on the results of this SBC for family planning 
business case to help countries more effectively and 
efficiently achieve their health and development goals. 
28See Breakthrough RESEARCH’s SBC Costing Guidelines for more 
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APPENDICES
Appendix 1   
Methods for impact literature 
review and extraction
The objective of the impact literature extraction was to 
generate evidence-based summary ORs that link SBC 
interventions to an increase in mCPR. This requires sum-
marizing evidence in three main categories: 
1.. Link from SBC interventions to intermediate 
variables.
2.. Link from intermediate variables to mCPR. 
3.. Direct link from SBC interventions to mCPR.
From SBC interventions to intermediate out-
comes and mCPR: impact extraction from HC3 
and FP Goals databases
When linking SBC interventions to outcomes, analysts did 
not conduct a new comprehensive search for SBC impact 
literature, because of previous comprehensive searches 
(up to the publication year of 2016) for the HC3 database 
and for the FP Goals model. All studies from the HC3 
database coded as family planning or empowerment, and 
all non-duplicative studies from the FP Goals database 
coded with a type of SBC intervention (e.g., communi-
cation, mass media, social marketing) were subject to 
abstract and (if eligible) full-text review. Additionally, 
studies from the SBC cost extraction with relevant impact 
data were also included.
The inclusion criteria were: (1) described an SBC inter-
vention; (2) was in English, Spanish, or French; (3) the 
study was located in a World Bank designated low- or 
middle-income country at the time of the study; (4) the 
study needed to have a comparison group (at minimum 
a study design with intervention/control, pre/post, or 
exposed/unexposed groups); and (5) included a family 
planning use outcome (e.g., mCPR). In addition to the 
family planning use outcome, analysts extracted other 
relevant behavior change outcomes related to:
• Improved attitudes of individuals and members of 
the household.
• Improved social norms in community.
• Better joint decision-making in the household.
• Improved communication about family planning. 
Given the heterogeneity of knowledge indicators and the 
more distal nature of changes in knowledge in the causal 
chain leading to behavior change outcomes, knowledge 
indicators were not extracted. 
Extractors captured data from each included study using 
a study extraction template in Microsoft Excel, which 
included the SBC intervention category, intervention 
details, study location, populations the intervention 
aimed to reach, study design, sample sizes, effect sizes, 
type of ratio provided, and the level of significance asso-
ciated with the effect size. 
In total, 288 family planning studies were initially 
screened, with 211 meeting the inclusion criteria and 
extracted. Among these, approximately 20 percent were 
double-extracted to ensure quality and consistency 
between the four data extractors. 
Linking SBC to intermediate outcomes
Initially, the WHO/3ie mapping framework was used 
to classify interventions and intermediate outcomes 
(Portela et al. 2017). This classification, however, proved 
difficult to operationalize in the extracted data, with 
many categories not having sufficient observations to 
aggregate across studies. As such, the SBC intervention 
classification of each line item in the impact extraction 
database was reviewed and classified as one of three 
major intervention types: (1) mass media, (2) IPC, and (3) 
intervention packages. Intervention packages typically 
consisted of community-based mobilization that relied on 
a combination of mass media, counseling, and provider 
training. 
The specific outcomes for each extracted line item were 
categorized into one of four outcome categories: 
1.. Overall modern contraceptive use.
2.. Method-specific modern contraceptive use (e.g., IUD 
adoption, condom use).
3.. Intermediate outcomes related to family planning, 
including beliefs, attitudes, and communication.
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4.. Other family planning related outcomes (e.g., 
increased birth spacing, pregnancy, age at first birth).
Intermediate outcomes were first divided into two 
groups: (1) beliefs/attitudes about family planning 
and (2) communication about family planning. Next, 
these outcomes were further classified to capture 
different dimensions of these intermediate outcomes 
with an effort to be consistent with other theoretical 
frameworks. After two rounds of review and broader 
consultation with the research team, the intermediate 
outcomes included:
1.. Beliefs related to the approval of family planning.
2.. Attitudes related to the benefits of family planning 
and safety and efficacy.
5.. Attitudes on intentions and self-efficacy around 
family planning use.
6.. Attitudes related to the role of men in family 
planning.
7.. Communication between partners.
8.. Communication with others such as friends and 
family members.     
When combining these eight categories with the SBC 
intervention types, each intermediate outcome observa-
tion could be classified into one of 20 different “buckets” 
that could be used to estimate the relationship between 
the SBC intervention and intermediate outcome. Note 
that not all outcome subcategories were identified for all 
intervention types (Table 6).
To find a common metric within the buckets, an OR was 
sought for each intermediate outcome observation. For 
many observations, the ORs (or AORs) were reported and 
TABLE 6  ODDS RATIOS, RELATIONSHIP BETWEEN SBC INTERVENTIONS AND INTERMEDIATE  
                 OUTCOMES, MEDIAN, 25TH PERCENT LOWER BOUND, 75TH PERCENT UPPER BOUND
OUTCOME INTERVENTION # STUDIES Q1 MEDIUM Q3
Beliefs—approval of family planning Mass media 9 1.11 1.58 1.78
IPC 6 1.22 1.23 1.73
Packages 16 1.33 1.61 2.13
Attitudes on the benefits/safety/effectiveness 
of family planning
Mass media 4 1.05 1.09 1.15
IPC 2 1.71 1.71 2.48
Packages 7 1.35 1.64 2.20
Attitudes intention/self-efficacy of family 
planning
Mass media 7 0.78 1.04 1.14
IPC 7 0.95 1.57 1.87
Packages 7 1.20 1.29 1.47
Attitudes of men's role in family planning Mass media 2 1.29 1.55 1.80
IPC 2 1.14 1.26 1.37
Packages 4 1.03 1.59 3.62
Communication between partners Mass media 12 1.11 1.24 1.95
IPC 1 1.54 1.54 1.54
Packages 8 1.18 2.10 3.79
Communication with others Mass media 7 1.26 1.79 2.19
IPC 2 0.97 0.97* 1.36
Packages 6 1.35 1.45 1.60
*For the modeling this OR was entered as 1 so this intervention would have no effect on communication with others; if the .97 was included there would 
be an associated decline in this outcome. 
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already extracted. In other instances, the ORs needed to 
be calculated from extracted data, most commonly using 
pre-post percentage data. Logistic regression coeffi-
cients were exponentiated; however, linear regression 
coefficients were not utilized since they could not be 
converted to ORs. 
Within each bucket, a study was limited to one observa-
tion to represent the strength of the association between 
the intervention and outcome. If a study had multiple 
observations within a bucket, either the ORs were aver-
aged or the best representative observation was chosen. 
For example, if the study reported findings from multiple 
sites, the researcher averaged the ORs across sites to get 
the average effect size. In contrast, if multiple outcomes 
in the same bucket were presented and one outcome 
was clearly more representative of the intermediate out-
come, the researcher selected that outcome to represent 
the study. If the appropriate approach was not clear, 
the researcher consulted the broader research team for 
consensus on the best approach. In total, 55 studies feed 
into the matrix.
Analysts used a simple weighting process to factor in the 
strength of study design in aggregating across stud-
ies. Each study was given a score of 1–3 based on the 
following study designs: (1) cross sectional and pre-post 
only studies, (2) pre-post with control group or studies 
with advanced analytical techniques that approximate 
pre-post with control findings (e.g., propensity score 
matching), and (3) randomized controlled trials. After 
weighting, the median, range, and interquartile range 
(Q1 = 25th percentile lower bound; Q3 = 75th percentile 
upper bound) OR value were calculated for each bucket 
to represent the relationship between the SBC interven-
tion and the intermediate outcome (Table 6).
Direct linkages from SBC interventions to mCPR
Prior work developing the FP Goals model29 reviewed 
the literature to generate ORs used for estimating the 
increases to mCPR based on family planning interven-
tions, including SBC interventions. To avoid duplication of 
efforts and to ensure consistency with already reviewed 
and peer-reviewed processes, the FP Goals findings 
served as the foundation of linking SBC interventions 
directly to mCPR. The three sub-intervention categories 
used in FP Goals mapped well to the mass media, IPC, 
and packages categories for this analysis; however, a 
29http://www.track20.org/pages/our_work/innovative_tools/FPgoals.php
provider behavior change intervention category was not 
captured in FP Goals.
Since FP Goals was not limited to SBC, FP Goals classified 
some SBC interventions in other sub-categories such 
as youth or postpartum family planning. In these cases, 
the findings were reclassified into the mass media, IPC, 
or packages categories based on the description of 
the intervention. Next, the HC3 database entries were 
reviewed to identify additional outcomes that could be 
added into FP Goals for updated median ORs. Data from 
26 additional studies were included in FP Goals. 
Table 7 details the median ORs from the original FP Goals 
matrix to the updated ORs once youth and postpartum 
ORs were reclassified and additional ORs from the 
extraction database were included.
Linking intermediate outcomes to modern con-
traceptive use
Three research steps were taken to find literature that 
would link intermediate outcomes to modern contra-
ceptive use. First, each study from the review process 
described above with intermediate outcomes was 
reviewed to ascertain whether the analysis modeled 
modern contraceptive use as a function of interme-
diate variables. This yielded eight studies. Second, a 
PubMed search was conducted to capture studies that 
predicted modern contraceptive use as a function of 
intermediate variables that would not have been iden-
tified in the other searches because they did not focus 
on SBC interventions. A total of 1,525 abstracts were 
identified, 476 of which were reviewed; of these, 29 had 
relevant data which were included. Finally, a series of 
supplemental searches of Google Scholar, and review of 
citations in included studies were used to identify nine 
additional studies. In total, 46 studies were identified 
TABLE 7  ODDS RATIOS, DIRECT IMPACT OF SBC 
                INTERVENTION ON MODERN  
                CONTRACEPTIVE PREVALENCE





Mass media 1.3 1.3 [1.1–1.5]
IPC 1.5 1.6 [1.2–2.0]
Packages 1.3 1.4 [1.2–1.6]
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with quantitative findings linking intermediate outcomes 
to modern contraceptive use. Some studies had multiple 
findings in that more than one intermediate outcome 
was used to predict modern contraceptive use. Each 
finding was classified as an observation into the eight 
intermediate outcome buckets.
When studies had multiple observations in a bucket, 
they were either combined or the preferred observation 
was selected. In some cases, more than one obser-
vation per study was allowed if the results were from 
different countries or if outcomes represented different 
dimensions of the concept within the same bucket (for 
example, under attitudes on the benefits, safety, and 
effectiveness of family planning, two outcomes from a 
study were included—attitude that family planning meth-
ods are effective and belief that family planning causes 
cancer). For each bucket, the median, range, and inter-
quartile range (Q1 = 25th percentile lower bound; Q3 = 
75th percentile upper bound) were calculated (Table 8). 
Appendix 2 
Methods for cost literature 
extraction and analysis
Literature search
A literature search found 130 cost studies from which we 
extracted 711 cost estimates (Figure 14). First, a search 
of the peer-reviewed SBC cost literature was conducted 
using PubMed. The peer-reviewed literature search terms 
were designed to capture the intersection between cost-
ing information, SBC interventions, and key health areas. 
No date restrictions were specified in order to capture as 
many cost studies as available. The final search terms are 
listed at the end of this appendix. On 8 July 2018, these 
search terms yielded 6,403 hits for abstract review by the 
SBC Cost Study Repository development team.
Each retrieved abstract was downloaded into an EndNote 
8.0 library and reviewed based on four criteria: (1) 
described an SBC intervention; (2) indicated the inclusion 
of cost data; (3) was in English, Spanish, or French; and 
(4) the study was conducted in a World Bank designated 
low- or middle-income country at the time the study. 
Among the 6,403 abstracts, the majority (n=4,732) 
were excluded because they did not describe an SBC 
intervention. Another 1,395 abstracts were excluded 
because they did not indicate that the study included 
cost data and 70 were excluded because they were not 
conducted in low- or middle-income countries. A total of 
206 abstracts that met all four criteria were sought for a 
full-text review.
Since the search had no date limitation, many stud-
ies dated back to the 1970s and 1980s and were not 
available from electronic databases. As such, only 147 
TABLE 8  ODDS RATIOS, IMPACT OF INTERMEDIATE OUTCOMES ON MODERN CONTRACEPTIVE  
                PREVALENCE
OUTCOME # OR Q1 MEDIAN Q3
Beliefs regarding approval of family planning 31 1.4 1.9 3.4
Attitudes on the benefits, safety, and effectiveness of planning 7 1.3 1.5 2.1
Attitudes around intentions and self-efficacy of family planning 7 1.1 1.4 2.4
Attitudes regarding men’s role in family planning 8 1.0 1.1 2.2
Family planning communication between partners 34 2.0 2.8 3.8
Communication with others about family planning 8 1.4 1.5 3.0
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peer-reviewed studies from the PubMed search were 
available for full-text review. Among these, the following 
additional criteria were applied: (5) studies had cost 
estimates that were clearly and accurately reported in 
tables or text, (6) studies had some primary/empirical 
data reported and/or analyzed, (7) and the source of the 
data was reported. 
Each full-text study was also reviewed for references 
to other relevant SBC cost studies and when identified, 
secondary sources were sought. Secondary sources 
were also drawn from the HIV and TB Unit Cost Study 
Repository and from studies reviewed for the SBC Impact 
Data Repository that were flagged by the reviewer as 
having potentially usable cost data, for a total of 63 sec-
ondary sources subject to full-text review. Additionally, 
a targeted grey literature review was conducted in 
POPLINE, Google Scholar, and on organizational websites 
(e.g., USAID, PSI, Population Council, FHI360). For the 
grey literature search, the targeted POPLINE searches 
generated 753 abstracts, and 60 studies were retrieved 
for full-text review. Of the 270 studies from the cost 
literature search, secondary sources, and grey literature 
that were full-text reviewed, 140 were excluded for the 
following reasons: 64 were not SBC; 28 had no primary/
empirical data; 5 were not from low- or middle-income 
countries; 20 had no clear source for the cost data; 1 had 
erroneous data and there was no response after contact-
ing the author; 6 were duplicates of another study that 
had a different publication year or first author; 4 listed 
only a budget and it was not clear what was spent; 7 had 
a data format that was unclear and the data couldn’t be 
interpreted; and 5 omitted major cost categories for the 
intervention type. In total, 130 cost studies were included 









POPLINE Grey LIt Search
N = 753
Excluded:
64 not SBC (46%); 28 no primary/empirical data (20%); 5 not LMIC (4%); 
20 no clear source for cost data (14%); 1 erroneous data (1%); 6 duplicate of 
another study (4%); 4 budget unclear on what was spent (3%); 7 data format 
unclear/can’t interpret (5%); 5 omitted major cost categories (4%)
Full text reviewed: 
grey sources
N = 60
Full text reviewed: 
studies identified through 
secondary sources
N = 63









4,732 not SBC (76%)
1,395 no cost data (23%)
70 not relevant to LMIC (1%)
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from all sources: 75 from the cost literature search, 31 
from secondary sources, and 24 from the grey literature 
search. From these included studies, 711 cost estimates 
were extracted, there being more cost estimates than 
studies because most studies had multiple cost estimates 
based on different geographic areas, populations, or SBC 
intervention components (see Figure 14 for more details).
Data from each included study were captured using 
a study extraction template in Microsoft Excel, which 
included the health area, SBC intervention category and 
sub-category, intervention details, study location, and 
population/s (category; and number aiming to reach, 
exposed, and/or participated). Costing experts and SBC 
program implementers were consulted in the design 
of the data extraction form and several sources were 
used to ensure alignment of the priority fields, including 
the Reference Case for Estimating the Costs of Global 
Health Services and Interventions (Vassall et al. 2017), 
the PrEP Costing Guidelines (DeCormier Plosky et al. 
2018), the Guidelines for Costing of Social and Behavior 
Change Health Interventions (Rosen et al. 2019), the 
primer on costing of Social Norms Interventions (Homan 
2016), and the Unit Cost Study Repository (Global Health 
Cost Consortium 2019). To capture costs, columns 
were included for detailed extraction of the cost data, 
including type of cost (e.g., total cost or unit cost), unit of 
measurement, economic/financial cost, cost perspective, 
intervention phase, reported currency and currency year, 
the cost disaggregation (into the categories of personnel, 
commodities, other recurrent costs, and capital costs), 
revenue, client cost, whether scale was discussed in the 
paper, and reporting of any calculations Avenir Health did 
to create or adjust a unit cost from the study. 
Cost data extraction occurred from June to December 
2018 by two data extractors. The study manager 
reviewed two initial studies per extractor to provide 
feedback and improve accuracy and consistency. 
Extractors received detailed instructions, and weekly 
meetings were held to answer additional questions. Once 
extraction was completed, the cost data were cleaned 
by the study manager for key columns (e.g., number 
trying to reach, number exposed, denominator explana-
tion, cost type, unit of measurement, cost per output, 
economic/financial cost, cost perspective, intervention 
phase, author reported currency).
Cost data analysis
Analysis of the cost data began with standardizing all cost 
data to 2017 USD, in alignment with the process used by 
the Global Health Cost Consortium. First, we reviewed 
the reported year of the cost data, and where the study 
author did not give a year for the reported cost data, a 
formula was used that took the publication date and sub-
tracted one year. In cases where the reported currency 
was not in USD, the currency was then converted to 
USD by using the market exchange rate published by the 
World Bank30 for the reported year of the cost data. Once 
all cost data was in USD, the costs were then inflated 
to 2017 USD using the US GDP Price Deflator from the 
World Bank31 (note that 2017 was the latest year available 
at the time of the analysis).
To try to isolate for costs that are comparable, all cost 
data were then filtered to separate the analysis by 
intervention category, and select for the cost type, unit 
of measurement, and intervention phase appropriate 
to that intervention category. Data were then sorted by 
intervention type, health area, cost type, and study lead 
author. With the data filtered and sorted, an additional 
quality review was conducted to strive for greater con-
sistency and comparability. Each unit cost was verified 
as representing costs per person exposed or per person 
participating, requiring the study manager to calculate 
from other reported data in several instances. Outliers 
(high or low cost for what the study manager subjectively 
determined to be “typical” implementation by inter-
vention type) were further reviewed for an explanation. 
If one was found that would require reclassification of 
intervention type or adjustments of the cost (e.g., to 
remove medical commodities), those actions were taken, 
and the unit cost was listed for inclusion in the analysis. If 
none was found, or the explanation (e.g., a denominator 
that was not completely clear; supervision that seemed 
more intensive than in other studies; there were struc-
tural intervention components) did not disqualify use of 
the unit cost (e.g., major cost categories for the interven-
tion type were omitted, medical commodity costs could 
not be disaggregated and were a significant portion of 
the cost), it was listed as an outlier.
Analysis for the minimum, first quartile, mean, median, 
third quartile, and maximum was then conducted for 
each intervention category and type. Separate analysis 
was done for the costs inclusive of outliers, without out-
liers, and only for the outliers. In alignment with the use 
30Exchange rates available at: https://data.worldbank.org/indicator/
PA.NUS.FCRF
31US GDP Price Deflator: https://data.worldbank.org/indicator/NY.GDP.
DEFL.ZS
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of the median for impact estimates, it was decided that 
the median costs for each cost type exclusive of outliers 
would be drawn into the modeling work.
Resulting unit cost estimates
The results of the cost analysis are in Table 9. Of the 711 
cost estimates in the SBC Cost Study Repository, there 
were 94 that were used for the analysis in Table 9 (from 
53 unique studies) for the “excluding outliers” column 
and 130 estimates (from 70 unique studies) for the “with 
outliers” column. Exclusion of estimates from the SBC 
Cost Study Repository from the analysis was primarily 
because: the estimate did not meet one of the filter crite-
ria for standardization (e.g., a cost type other than a unit 
cost such as a total cost of cost-effectiveness estimate; 
a client cost perspective; design phase costs only), the 
estimate had a denominator that was not comparable to 
those used in the analysis (e.g., per person in the area or 
per person targeted), or the estimate was coded “no” in 
the analysis because of methodological issues (e.g., the 
denominator was not clearly defined; critical costs omit-
ted; couldn’t disaggregate the service costs from the SBC 
costs). As in the case of the impact data, one study may 
have multiple observations for the same intervention 
type and/or multiple observations across intervention 
types, and therefore the number of studies in the right 
column of Table 9 does not equate to the unique number 
of studies in the analysis. Note that all costs are reported 
in 2017 US dollars. The units for “Mass media” interven-
tions are per person exposed, with the exception of “SMS 
(texting)/phone call,” which is considered to be partici-
patory. The units for the IPC and package interventions 
are per person participated. Note that the “Mass media” 
category is listed as per person exposed, even though the 
TABLE 9  MEDIAN AND INTERQUARTILE RANGE FOR SBC INTERVENTION COSTS, EXCLUDING AND 
                WITH OUTLIERS
INTERVENTION MEDIAN & INTERQUARTILE 
RANGE
(EXCLUDING OUTLIERS)
MEDIAN & INTERQUARTILE 
RANGE
(WITH OUTLIERS)
# STUDIES (STD.)/ 
OBSERVATIONS (OBS.)
(# WITH OUTLIERS IN  
PARENTHESES)
Mass media $0.25 [$0.12–$0.75] $0.35 [$0.12–$1.99] 20 std./33 obs. (23 std./45 obs.)
  Radio $0.26 [$0.14–$0.75] $0.26 [$0.13–$1.29] 6 std./9 obs. (8 std./11 obs.)
  TV $0.12 [$0.07–$0.25] $0.17 [$0.09–$0.39] 4 std./8 obs. (5 std./10 obs.)
  Billboards $0.18 [$0.15–$0.21] $0.25 [$0.12–$1.02] 2 std./2 obs. (4 std./5 obs.)
  Newspapers $0.30 [$0.30–$0.30] $0.30 [$0.16–$10.46] 1 std./1 obs. (3 std./3 obs.)
  Live drama $1.50 [$0.33–2.84] N/A (because no outliers) 3 std./4 obs. (N/A)
  Social marketing  $0.17 [$0.16–$0.17] $0.18 [$0.17–$1.97] 2 std./2 obs. (3 std./3 obs.)
  SMS/phone call $2.16 [$1.69–$2.74] $1.99 [$1.26–$2.45] 5 std./5obs. (5 std./7 obs.)
  Mixed mass media $0.34 [$0.19–$0.49] N/A (because no outliers) 2 std./2 obs. (N/A)
IPC $6.51 [$3.16–$15.58] $6.92 [$3.26–$18.23] 28 std./40 obs. (40 std./54 obs.)
  Group IPC $6.92 [$3.28–$15.58] $6.76 [$2.95–$15.52] 18 std./24 obs. (19 std./25 obs.)
  Individual IPC $5.04 [$3.22–$7.55] $7.55 [$5.01–$32.05] 8 std./13 obs. (17 std./23 obs.)
  Mixed IPC $44.28 [$23.64–$48.84] $5.96 [$1.57–$35.44] 3 std./3 obs. (6 std./6 obs.)
Packages (all) $10.23 [$2.06–$20.90] $11.16 [$1.92–$34.84] 17 std./21 obs. (24 std./31 obs.) 
  Community $1.69 [$0.80–$1.92] N/A (because no outliers) 6 std./7 obs. (N/A)
  IPC/Participation $20.90 [$17.51–$26.01] $31.93 [$20.90–$217.52] 6 std./7 obs. (11 std./13 obs.)
  IPC/Mass media/ 
  Education
$11.16 [$6.95–$25.38] $7.35 [$2.28–$12.09] 6 std./7 obs. (9 std./11 obs.)
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participatory intervention of “SMS (texting)/phone call” is 
included in the cost for the category. Similarly, the inter-
vention category of “Packages” and intervention type of 
“IPC/Mass Media” is listed as per person participated, 
even though some aspect of per person exposed through 
mass media is included in the cost. Technically, these 
categories could be listed as a mix of per person exposed 
and participated, but here they are designated by what 
comprised the majority of the cost. 
The medians excluding outliers and the medians includ-
ing outliers are similar, except for “Mixed IPC,” “IPC/
Participation,” and “IPC/Mass media/Education.” This is 
for two principal reasons. The first is that mixed (across 
intervention types in the same intervention category) or 
package interventions (mixed across intervention cate-
gories) often had insufficient detail in the intervention 
description to assess with confidence the components 
and intensity of the components that were included. 
Therefore, it was exceedingly difficult to understand what 
a “typical” intervention might be. Secondly, it was chal-
lenging to assess how the reported cost inputs related 
back to the reported mixed or package intervention com-
ponents. In addition, and as in the case of every outlier 
cost estimate, there were unique problems with study 
methodology and reporting that contributed to outlier 
status. For example, in the case of “Mixed IPC” there 
were three cost estimates coded for inclusion (with a 
median cost of $44.28) and three coded as outliers (with 
a median cost of $1.09). The large difference in these 
medians leads to the question of what “typical” imple-
mentation for mixed IPC would look like. Intervention 
descriptions in the studies did not allow for such assess-
ment, and the three outliers were then determined 
because of other issues with study methodology or 
reporting. In one case, the intervention was only for six 
days and it was unclear if components involving screen-
ing for malaria were included in the cost. In another, 
there were components of facility-based IPC and group 
IPC, but the group IPC piece was unclear, and it was diffi-
cult to assess to what extent it was included in the cost. 
For the third, the study author had cost estimates for 
multiple SBC interventions that were all lower than the 
cost estimates for comparable intervention types and it 
was difficult to verify which cost inputs referred to which 
intervention type. To improve standardization, all cost 
estimates from that author were listed as outliers.
For the cost estimates excluding outliers, the “Mass 
media” intervention category had the lowest cost 
(median of $0.25 per person exposed), and “Packages” 
had the highest (median of $10.23 per person participat-
ing). This is principally due to the unit (or denominator) 
for the unit costs (the total cost for the intervention in 
the numerator divided by the unit of measurement). 
While the mass media interventions are measured in 
units of “people exposed,” which can be a very large 
denominator if implemented nationally, IPC and packages 
are measured in units of “people participating,” which is 
usually conducted more locally and is a relatively small 
denominator. This could be thought of as the difference 
between SBC interventions that are communicating 
“at/to” people and those communicating more directly 
“with/among” people. It should be noted that the inter-
quartile ranges for the costs excluding outliers were wide 
both within each intervention type and within each inter-
vention category, due to the heterogeneity in how the 
interventions were implemented, costed, and reported; 
however, the interquartile ranges for the costs including 
outliers were much wider. In the case of the intervention 
type “IPC/[community mobilization or] participation,” 
the costs, including outliers, on the higher end of the 
interquartile range are from studies that are either for 
adolescents that are intensive (e.g., facility adaptations 
for privacy, many counseling sessions, or costly skill 
building components) or for stigmatized populations that 
include structural components to reduce bias among 
police, lawmakers, or mass media personnel. 
Finally, while the costs for “Mass media” are lower than 
those for “IPC” or “Packages,” caution should be taken 
with utilization of these estimates. It may be the case 
that different types of interventions are better suited for 
different purposes, such as scaling up IPC or packages 
when the intent is to reach those not initially con-
vinced by mass media or the issue is one of adherence. 
Therefore, the selection of SBC interventions for imple-
mentation will also need to be suited to the context, 
considered with respect to effectiveness, and conducted 
in accordance with national priorities.
PubMed SBC cost literature Search Terms
((((Cost[Title/Abstract] OR Price[Title/Abstract] OR 
“Health economic”[Title/Abstract] OR Dollar[Title/
Abstract] OR USD[Title/Abstract] OR $[Title/Abstract] 
OR €[Title/Abstract] OR £[Title/Abstract])) AND (SBC[Ti-
tle/Abstract] OR IPC[Title/Abstract] OR “Interpersonal 
counseling”[Title/Abstract] OR “Intrapersonal counsel-
ing”[Title/Abstract] OR “Face-to-face”[Title/Abstract] 
OR “Social marketing”[Title/Abstract] OR “Social 
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mobilization”[Title/Abstract] OR “Social change”[Title/
Abstract] OR “Socio-behavioral”[Title/Abstract] OR 
Socio-behavioural[Title/Abstract] OR “Change behav-
ior”[Title/Abstract] OR “Change behaviour”[Title/
Abstract] OR “Planned behavior”[Title/Abstract] OR 
“Planned behaviour”[Title/Abstract] OR “Behavior 
change”[Title/Abstract] OR “Behaviour change”[Title/
Abstract] OR “Behavioral change”[Title/Abstract] OR 
“Behavioural change”[Title/Abstract] OR “Behavioral 
economic”[Title/Abstract] OR “Behavioural economic”[Ti-
tle/Abstract] OR Attitude[Title/Abstract] OR Norm[Title/
Abstract] OR Tradition[Title/Abstract] OR Tradition-
al[Title/Abstract] OR “Demand creation”[Title/Abstract] 
OR “Demand generation”[Title/Abstract] OR “Demand 
generating”[Title/Abstract] OR “Generate demand”[Title/
Abstract] OR “Demand-side”[Title/Abstract] OR “Demand 
side”[Title/Abstract] OR mHealth[Title/Abstract] OR 
“M-health”[Title/Abstract] OR Adhere[Title/Abstract] 
OR Communication[Title/Abstract] OR Advocacy[Title/
Abstract] OR Outreach[Title/Abstract] OR Mobile[Title/
Abstract] OR Campaign[Title/Abstract] OR Media[Title/
Abstract] OR Advertise[Title/Abstract] OR Advertise-
ment[Title/Abstract] OR Entertain[Title/Abstract] OR 
Edutainment[Title/Abstract] OR Drama[Title/Abstract] OR 
SMS[Title/Abstract] OR “Text message”[Title/Abstract] 
OR Phone[Title/Abstract] OR Peer[Title/Abstract] OR 
“Behavioral design”[Title/Abstract] OR “Behavioural 
design”[Title/Abstract] OR “Design behave”[Title/
Abstract] OR “Human-centered design”[Title/Abstract] 
OR “Human centered design”[Title/Abstract] OR Radio[Ti-
tle/Abstract] OR Television[Title/Abstract] OR TV[Title/
Abstract])) AND (“Family planning”[Title/Abstract] OR 
Reproductive[Title/Abstract] OR Mother[Title/Abstract] 
OR Father[Title/Abstract] OR Couple[Title/Abstract] OR 
Pregnancy[Title/Abstract] OR Pregnancies[Title/Abstract] 
OR Pregnant[Title/Abstract] OR Birth[Title/Abstract] OR 
Contraception[Title/Abstract] OR Contraceptives[Title/
Abstract] OR HIV[Title/Abstract] OR AIDS[Title/Abstract] 
OR “Harm Reduction”[Title/Abstract] OR Integrated[Ti-
tle/Abstract] OR Integration[Title/Abstract] OR “Sector 
wide”[Title/Abstract] OR “Sector-wide”[Title/Abstract] 
OR “Health System”[Title/Abstract] OR Malaria[Title/
Abstract] OR Zika[Title/Abstract] OR Youth[Title/Abstract] 
OR Adolescent[Title/Abstract] OR “Newly married”[Title/
Abstract])) 
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Appendix 3 
Selection of case examples
From the literature review described in Appendices 1 
and 2, we used a series of selection criteria to highlight 
case examples most relevant to this business case (Figure 
15). We found 25 studies that had both cost and impact 
results. Of those, we then chose studies that were (1) 
published since 2000, (2) published in a peer-reviewed 
journal, (3) had outcome data related to modern con-
traceptive use, and (4) had a clear SBC intervention with 
costs specific to SBC. The two studies presented in this 
document, Robinson and Lewis 2003 and Kincaid and Do 
2006, matched those criteria.  
These were the only two studies that fit these crite-
ria, thus revealing gaps in the literature. That the two 
selected case studies both examined mass media inter-
ventions indicates a particular need for cost-effectiveness 
studies on the other SBC intervention categories (IPC, 
provider behavior change, and community mobilization 
packages). A challenge for the SBC field moving forward 
is to do more studies that, from the start, include a 
cost-effectiveness analysis of a broader range of SBC 
interventions, including those that integrate across 
health areas. 










Both impact & costs
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Appendix 4  
Modeling cost-effectiveness of SBC
Modeling the cost-effectiveness of SBC requires two 
parts—modeling the impact of SBC intervention on 
mCPR and subsequent health impacts and modeling the 
cost of SBC scale up (Figure 16). The modeling approach 
builds on previous modeling work including for HIV (Goals 
model)32, family planning (FP Goals model)33, and other 
health areas, e.g., maternal-child health, TB, malaria, 
noncommunicable diseases, and nutrition. The modeling 
utilizes the impact and cost matrices that came from an 
extensive literature review process (see Appendices 1 
and 2).
32For more information on the Goals model: http://www.avenirhealth.
org/software-spectrum.php
33For more information on the FP Goals model: http://track20.org/pages/
our_work/innovative_tools/family planninggoals.php
Model inputs
In addition to utilizing the impact and cost matrices, the 
data inputs in Table 10 are also used.
Modeling an increase in mCPR
The impact of scaling up SBC interventions on mCPR 
is modeled in two ways—first, indirectly through the 
intermediate outcomes, then, directly in order to capture 
any residual impact. 
Generally, for impacts, calculations account for the base-
line level, the change in coverage, and the OR associated 
with the change in coverage to estimate the end line 
level.
These sets of calculations are done three times, each 
utilizing a different impact matrix:
• Change in intermediate outcomes due to SBC scale 
up (indirect pt 1).
FIGURE 16  GENERAL APPROACH TO MODELING COST-EFFECTIVENESS OF SBC
Scale up SBC
interventions
Cost per additional user
Cost per pregnancy averted
Cost per DALY averted
Costs saved per $1 invested



























*Also includes direct service provision costs for additional users attributable to SBC interventions
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• Change in mCPR due to changes in intermediate 
outcomes (indirect pt 2).
• Change in mCPR due to SBC scale up (direct).
If the direct change in mCPR is larger than the indirect 
change in mCPR, this additional “residual” impact is 
included in the overall change (classified as “other”). 
Modeling health and economic impacts
The increase in mCPR translates into additional users by 
estimating the total users in 2018 and the total users 
in 2023. This calculation therefore accounts for both 
increases in mCPR as well as changes in the number of 
women of reproductive age.
The model assumes linear scale up over the five-year 
period. Therefore, interim “user-years” are calculated 
for 2019–2022 to account for both impacts and costs 
associated with the increase in users over the full time 
period. Figure 17 illustrates this concept. Take a scenario 
where 50 additional users are reached by 2023. In this 
illustration, each block represents 10 additional users. 
Cumulatively over the five-year period, there are a total 
of 150 additional user years (15 blocks). A similar concept 
is applied for the impacts—total impacts represent the 
cumulative impacts over the five years. 
Impacts are calculated based on the impact coefficients 
(see model inputs). For example, the number of preg-
nancies averted is calculated as the total number of 
additional user years x pregnancies averted per user. 
TABLE 10  ADDITIONAL DATA INPUTS FOR MODELING COST-EFFECTIVENESS OF SBC 
DATA SOURCE
Baseline information 
mCPR among all women in 2018 FP2020 Progress Report
Mean ideal number of children Most recent DHS
Women of reproductive age in 2018 and 2023 UN Population Division World Population Prospects 2017
Intermediate outcomes baseline levels See details in section 5
Scale up of SBC interventions
Increase in coverage for each intervention See details in section 5
Impacts averted coefficients
Pregnancies averted per user Country specific, based on FP2020 Core Indicators
DALYs averted per pregnancy averted Country specific, based on Impact 2 v5
Cost of an unintended pregnancy Country specific, based on Impact 2 v5
Direct cost of family planning service provision 
Commodity, supply, and personnel cost by method Sub-regional estimates from Adding It Up 2017
Method mix Most recent DHS
FIGURE 17  ILLUSTRATION OF THE CONCEPT  
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In addition to calculating the direct maternal and child 
health care savings, an estimate is also made of the cost 
saved due to averted productivity loss. Studies suggests 
that each DALY averted generates savings of between 1 
and 3 times GDP per capita. Range is calculated based on 
maternal DALYs averted and the country GDP per capita.
Modeling SBC costs
The increased coverage in SBC interventions is trans-
lated into the number of women reached by multiplying 
the change in coverage (a model input) by the number 
of reproductive aged women in 2023. Using the same 
approach as described above, cumulative units of women 
reached are calculated to account for the total reach 
over the five-year scale up period. For mass media, units 
are the number of people who recall a message; for 
IPC and packages, units are the number of people who 
participate. 
Modeling direct cost of family planning service 
provision
In order for additional users to exist, women must access 
contraceptive supplies and services. Therefore, the 
analysis takes into account not only the cost of the SBC 
interventions, but also the direct costs associated with 
the additional users. Based on the input data (direct 
cost per method and method mix), a weighted average 
cost per user is calculated. This is then multiplied by the 
estimated number of additional user years to estimate 
the five-year total costs associated with family planning 
service provision. 
Calculating cost-effectiveness 
Finally, the impact and cost estimates are brought 
together to estimate the cost per additional user, cost 
per unintended pregnancy averted, and cost per DALY 
averted. These are done using the total cost—meaning 
the SBC intervention cost plus the direct service delivery 
cost. The cost per DALY averted is benchmarked against 
the country’s GDP to determine cost-effectiveness using 
WHO guidance that any intervention below 1 GPD per 
capita is “highly cost effective” while an intervention 
falling between 1 and 3 times GDP per capita is “cost 
effective” (WHO Commission on Macroeconomics and 
Health 2001). 
Calculations of costs saved per USD invested are also cal-
culated by dividing the cost savings (from direct maternal 
and child health costs as well as productively loss) to the 
total cost (SBC intervention + direct service delivery).
Sensitivity testing
Sensitivity testing is conducted on both the impacts and 
costs. Generally, results presented represent using the 
median impact and cost values from the matrices. How-
ever, the model is also run using the interquartile range 
(lower bound = 25 percent, upper bound = 75 percent) in 
order to account for uncertainty in these estimates.
Limitations
Like all modeling, the results are only as good as the 
model inputs and assumptions. Care has been taken 
to use the best estimates available from existing data 
sources. Further, the results are meant to be illustra-
tive—if this package of SBC intervention is scaled up, this 
is the likely resulting cost-effectiveness. 
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